GNS Analyzing NCI-60 Panel for PGx Applications

Under its subcontract with SAIC-Frederick, GNS will use its REFS platform to assess NCI data on several oncology drugs.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories